Dr. Davids received his AB in Chemistry from Harvard College, his MD from Yale University School of Medicine, and his MMSc degree from Harvard Medical School. He trained in internal medicine at Weill-Cornell Medical Center and Memorial Sloan Kettering Cancer Center in New York City and completed his fellowship in hematology and oncology in the Dana-Farber/Partners Cancer Care Program. His postdoctoral lab training focused on the mechanisms underlying resistance to treatment in chronic lymphocytic leukemia (CLL). In 2011, Dr. Davids joined the faculty of Harvard Medical School and Dana-Farber Cancer Institute, where he is now Associate Professor of Medicine and Clinical Research Director in the Division of Lymphoma. He leads numerous clinical trials of novel combination regimens for patients with CLL and lymphoma. On the lab side he leads a group that uses novel techniques to study patient samples with a goal of predicting response to therapy and understanding resistance mechanisms.